Gene · 10381
Papers4,386
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,386
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer. | Cell Mol Life Sci | 2023 | 37646890 | PubTator, text mining | PubMed |
| Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers. | Front Cell Dev Biol | 2023 | 37645246 | PubTator, text mining | PubMed |
| Amyloid Precursor Protein (APP) Regulates Gliogenesis and Neurogenesis of Human Neural Stem Cells by Several Signaling Pathways. | Int J Mol Sci | 2023 | 37629148 | PubTator, text mining | PubMed |
| The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton's Jelly Stem Cells. | Int J Mol Sci | 2023 | 37629090 | PubTator, text mining | PubMed |
| A Model of iPSC-Derived Macrophages with TNFAIP3 Overexpression Reveals the Peculiarities of TNFAIP3 Protein Expression and Function in Human Macrophages. | Int J Mol Sci | 2023 | 37629049 | PubTator, text mining | PubMed |
| The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer's Disease Reveals New Insights for AD Study. | Int J Mol Sci | 2023 | 37628788 | PubTator, text mining | PubMed |
| A Novel Genetic Variant in MBD5 Associated with Severe Epilepsy and Intellectual Disability: Potential Implications on Neural Primary Cilia. | Int J Mol Sci | 2023 | 37628781 | PubTator, text mining | PubMed |
| Insights from a Computational-Based Approach for Analyzing Autophagy Genes across Human Cancers. | Genes (Basel) | 2023 | 37628602 | PubTator, text mining | PubMed |
| Congenital hypogonadotropic hypogonadism in a patient with a de novo POGZ mutation. | Eur J Endocrinol | 2023 | 37619992 | PubTator, text mining | PubMed |
| Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model. | Stem Cells Transl Med | 2023 | 37616288 | PubTator, text mining | PubMed |
| Mitochondrial impairment and synaptic dysfunction are associated with neurological defects in iPSCs-derived cortical neurons of MERRF patients. | J Biomed Sci | 2023 | 37605213 | PubTator, text mining | PubMed |
| TUBB3 and KIF21A in neurodevelopment and disease. | Front Neurosci | 2023 | 37600020 | PubTator, text mining | PubMed |
| Clinicopathological significance of TUBB3 in upper tract urothelial carcinoma and possible application in urine cytology. | Pathol Int | 2023 | 37589430 | PubTator, text mining | PubMed |
| Protocol for designing and bioprinting multi-layered constructs to reconstruct an endothelial-epithelial 3D model. | STAR Protoc | 2023 | 37585294 | PubTator, text mining | PubMed |
| A sex-specific thermogenic neurocircuit induced by predator smell recruiting cholecystokinin neurons in the dorsomedial hypothalamus. | Nat Commun | 2023 | 37582805 | PubTator, text mining | PubMed |
| Microfluidic one-step synthesis of a metal-organic framework for osteoarthritis therapeutic microRNAs delivery. | Front Bioeng Biotechnol | 2023 | 37576986 | PubTator, text mining | PubMed |
| Multi-Target Neural Differentiation (MTND) Therapeutic Cocktail to Suppress Brain Tumor. | Int J Mol Sci | 2023 | 37569705 | PubTator, text mining | PubMed |
| Adipose-Derived Stem Cells Spontaneously Express Neural Markers When Grown in a PEG-Based 3D Matrix. | Int J Mol Sci | 2023 | 37569515 | PubTator, text mining | PubMed |
| Automated Capture and Analysis of Circulating Tumor Cells in Pediatric, Adolescent and Young Adult Patients with Central Nervous System Tumors. | Cancers (Basel) | 2023 | 37568669 | PubTator, text mining | PubMed |
| Update in Lung Cancer Molecular Pathology: Technological Advances and Clinical Practice. | Cancers (Basel) | 2023 | 37568629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10381/papers?page=19